124153

Trust spillovers among national and European institutions Source: Erasmus University Rotterdam (Article ID: 124153)

A 2026 study in Life Sciences (Article 124153 ) examines how specific viruses can suppress oral cancer by inducing a form of cell death known as ferroptosis . 124153

This 2025 review article explores the evolution of , which are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Antibody–Drug Conjugates: The Past

Researchers are now focusing on overcoming drug resistance and expanding ADCs beyond oncology to treat autoimmune and infectious diseases. 2. Political Science: Trust in European Institutions 124153

ADCs combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs, allowing them to kill cancer cells while sparing healthy tissue.

Early challenges included drug instability and low potency, leading to many failed clinical trials in the late 20th century.

Antibody–Drug Conjugates: The Past, Present and Future Source: Annual Review of Cancer Biology (DOI: 10.1146/annurev-cancerbio-070824-124153)